Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CXCL11 elevation
i
Other names:
CXCL11, C-X-C Motif Chemokine Ligand 11, I-TAC, H174, IP-9, Small Inducible Cytokine Subfamily B (Cys-X-Cys), Member 11, Interferon-Inducible T-Cell Alpha Chemoattractant, Interferon Gamma-Inducible Protein 9, Chemokine (C-X-C Motif) Ligand 11, C-X-C Motif Chemokine 11, Beta-R1, SCYB11, SCYB9B, B-R1, Small Inducible Cytokine Subfamily B (Cys-X-Cys), Member 9B, Small-Inducible Cytokine B11, ITAC, IP9
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
6373
Related biomarkers:
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
CXCL11 elevation
Follicular Lymphoma
CXCL11 elevation
Follicular Lymphoma
duvelisib
Resistant: C3 – Early Trials
duvelisib
Resistant
:
C3
duvelisib
Resistant: C3 – Early Trials
duvelisib
Resistant
:
C3
CXCL11 elevation
Renal Cell Carcinoma
CXCL11 elevation
Renal Cell Carcinoma
pazopanib
Resistant: C3 – Early Trials
pazopanib
Resistant
:
C3
pazopanib
Resistant: C3 – Early Trials
pazopanib
Resistant
:
C3
CXCL11 elevation
Renal Cell Carcinoma
CXCL11 elevation
Renal Cell Carcinoma
sunitinib
Resistant: C3 – Early Trials
sunitinib
Resistant
:
C3
sunitinib
Resistant: C3 – Early Trials
sunitinib
Resistant
:
C3
CXCL11 elevation
Renal Cell Carcinoma
CXCL11 elevation
Renal Cell Carcinoma
sunitinib + pazopanib
Resistant: C3 – Early Trials
sunitinib + pazopanib
Resistant
:
C3
sunitinib + pazopanib
Resistant: C3 – Early Trials
sunitinib + pazopanib
Resistant
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.